{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"50"}],"units":"Participants"}],"groups":[{"description":"This is a stratified single-armed phase II study designed to investigate the safety and efficacy of hematopoietic cell allografts administered after nonmyeloablative cytoreduction.","id":"OG000","title":"TREATMENT OF LYMPHOHEMATOPOIETIC MALIGNANCIES"}],"paramType":"NUMBER","populationDescription":"Population is defined as all participants who received transplant as per protocol.","reportingStatus":"POSTED","timeFrame":"24 months post transplant","title":"Overall Survival","type":"PRIMARY","unitOfMeasure":"participants"}